Linde (NYSE: LIN; FWB: LIN) and Bluefors announced in a joint statement that they have joined forces to create cooling solutions for large-scale quantum computers. Linde is contributing its vast experience as the world leader for large cryogenic installations. Bluefors brings to the table its ultra-low temperature interface needed for quantum computing. Their combined effort supports this emerging industry by ensuring cryogenics are ready for the next steps in large-scale quantum computing, in terms of cooling power, efficiency and robustness.
In the initial phase of the partnership, the companies focused on identifying how the technologies work best together. Currently, both partners are collaborating on implementing the results to get their joint product ready for market.
“I am happy that we, as two world leaders within their respective sectors, take on this challenge,” says John van der Velden, Senior Vice President Global Sales & Technology, Linde Engineering. “The market potential for the technology is significant, since quantum computing will enable complex or real-time task processing, to name just a few examples: in healthcare modeling, banking and finance, autonomous driving, machine learning, and artificial intelligence.”
“After our first meetings, it was clear to both Bluefors and Linde that this was a perfect match for the next phases,” comments Rob Blaauwgeers, CEO Bluefors. “Linde shares the same values regarding product quality and reliability and has a long experience in providing large scale cryogenics, which is a necessity in the next steps of quantum computing scale-up.”
Quantum computers have the potential for computational power that is unattainable by current computers. They can operate exponentially faster than conventional computers and could, thereby, be the solution to today’s insurmountable problems. Cryogenics is a critical component in harnessing this quantum power and the ability to cool down large-scale quantum circuits is essential. Together, Linde and Bluefors have embraced this challenge to ensure that the next stage in cryogenics is ready and able to meet this need.